E-LIB Suche - Ergebnisse für: Dunne, Lina W.

1

Harnessing the synergy of perfusable muscle flap matrix and..:

Zhang, Qixu ; Chiu, Yulun ; Chen, Youbai...
Bioactive Materials. 22 (2023) - p. 588-614 , 2023

Link: https://doi.org/10.1016/..

2

Silk Fibroin-Decorin Engineered Biologics to Repair Musculo..:

, In: Regenerative Medicine and Plastic Surgery,

Dunne, Lina W. ; Falk, Nadja ; Hubenak, Justin... - p. 325-346 , 2019

Link: https://doi.org/10.1007/..

3

About the Authors:

, In: Nanotechnology in Cancer,

Altan, Cem L. ; Blumenauer, Brian ; Clemens, Mark W.... - p. xi-xv , 2017

Link: https://doi.org/10.1016/..

4

Decellularized skin/adipose tissue flap matrix for engineer..:

Zhang, Qixu ; Johnson, Joshua A. ; Dunne, Lina W....
Acta Biomaterialia. 35 (2016) - p. 166-184 , 2016

Link: https://doi.org/10.1016/..

5

Characterization of dielectrophoresis-aligned nanofibrous s..:

Dunne, Lina W. ; Iyyanki, Tejaswi ; Hubenak, Justin.
Acta Biomaterialia. 10 (2014) 8 - p. 3630-3640 , 2014

Link: https://doi.org/10.1016/..

6

Human decellularized adipose tissue scaffold as a model for..:

Dunne, Lina W. ; Huang, Zhao ; Meng, Weixu...
Biomaterials. 35 (2014) 18 - p. 4940-4949 , 2014

Link: https://doi.org/10.1016/..

7

Harnessing the synergy of perfusable muscle flap matrix and..:

Zhang, Qixu ; Chiu, Yulun ; Chen, Youbai...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646752/. , 2022

Link: http://www.ncbi.nlm.nih...

8

Adipose-Derived Stem-Cell-Seeded Non-Cross-Linked Porcine A..:

Iyyanki, Tejaswi S ; Dunne, Lina W ; Zhang, Qixu...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334099/. , 2015

Link: http://www.ncbi.nlm.nih...

9

Harnessing the synergy of perfusable muscle flap matrix and..:

Qixu Zhang ; Yulun Chiu ; Youbai Chen...
http://www.sciencedirect.com/science/article/pii/S2452199X22004479. , 2023

Link: https://doi.org/10.1016/..

10

383. Pharmacokinetics and Safety in Healthy Adults of RSM01..:

Levi, Micha ; Watson, Shayne ; Anderson, Aparna B...
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

11

2106. Desirability of Outcome Ranking (DOOR): Application t..:

Aronin, Steven I ; Dunne, Michael W ; Gupta, Jayanti.
Open Forum Infectious Diseases. 10 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

12

Applying Desirability of Outcome Ranking End Point to Rando..:

Dunne, Michael W ; Aronin, Steven I ; Das, Anita F...
Clinical Infectious Diseases. 76 (2023) 12 - p. 2213-2215 , 2023

Link: https://doi.org/10.1093/..

13

Applying Desirability of Outcome Ranking End Points:

Dunne, Michael W ; Aronin, Steven I ; Das, Anita F...
Clinical Infectious Diseases. 77 (2023) 1 - p. 159-161 , 2023

Link: https://doi.org/10.1093/..

14

Antithrombotic Prophylaxis with Rivaroxaban in Patients wit..:

Hsia, Judith ; Spyropoulos, Alex C. ; Piazza, Gregory...
Thrombosis and Haemostasis. 124 (2023) 7 - p. 649-655 , 2023

Link: https://doi.org/10.1055/..

15

Mortality after a first‐ever unprovoked seizure:

Pang, Elaine W. ; Lawn, Nicholas D. ; Lee, Judy.
Epilepsia. 64 (2023) 5 - p. 1266-1277 , 2023

Link: https://doi.org/10.1111/..